• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. Studies Fail to Back Medtronic Claims

    Studies Fail to Back Medtronic Claims

  2. LONDON MARKETS: Oil Firms Boost FTSE 100 After Upgrade

    LONDON MARKETS: Oil Firms Boost FTSE 100 After Upgrade

  3. LONDON MARKETS: Oil Firms Boost FTSE 100 After Upgrade

    LONDON MARKETS: Oil Firms Boost FTSE 100 After Upgrade

  4. Glaxo Probes China Bribe Claims

    Glaxo Probes China Bribe Claims

  5. Aqua Pharmaceuticals Acquires Verdeso® Foam

    Aqua Pharmaceuticals Acquires Verdeso® Foam

  6. Elan Issues Response Document Further Detailing Inadequacy of Royalty Pharma's Revised Offer

    Elan Issues Response Document Further Detailing Inadequacy of Royalty Pharma's Revised Offer

  7. U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

    U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

  8. GlaxoSmithKline Reports Clinical Data for Votrient

    GlaxoSmithKline Reports Clinical Data for Votrient

  9. UPDATE: Evidence Mounts for Immunotherapies to Treat Cancer

    UPDATE: Evidence Mounts for Immunotherapies to Treat Cancer

  10. Evidence Mounts for Immunotherapies to Treat Cancer

    Evidence Mounts for Immunotherapies to Treat Cancer

12345
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.